Nickel Sensitivity Is Associated with GH-IGF1 Axis Impairment and Pituitary Abnormalities on MRI in Overweight and Obese Subjects.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Dec 2020
Historique:
received: 25 09 2020
revised: 10 12 2020
accepted: 18 12 2020
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 10 4 2021
Statut: epublish

Résumé

Nickel (Ni) is a ubiquitous metal, the exposure of which is implied in the development of contact dermatitis (nickel allergic contact dermatitis (Ni-ACD)) and Systemic Ni Allergy Syndrome (SNAS), very common among overweight/obese patients. Preclinical studies have linked Ni exposure to abnormal production/release of Growth Hormone (GH), and we previously found an association between Ni-ACD/SNAS and GH-Insulin-like growth factor 1 (IGF1) axis dysregulation in obese individuals, altogether suggesting a role for this metal as a pituitary disruptor. We herein aimed to directly evaluate the pituitary gland in overweight/obese patients with signs/symptoms suggestive of Ni allergy, exploring the link with GH secretion; 859 subjects with overweight/obesity and suspected of Ni allergy underwent Ni patch tests. Among these, 106 were also suspected of GH deficiency (GHD) and underwent dynamic testing as well as magnetic resonance imaging for routine follow up of benign diseases or following GHD diagnosis. We report that subjects with Ni allergies show a greater GH-IGF1 axis impairment, a higher prevalence of Empty Sella (ES), a reduced pituitary volume and a higher normalized T2 pituitary intensity compared to nonallergic ones. We hypothesize that Ni may be detrimental to the pituitary gland, through increased inflammation, thus contributing to GH-IGF1 axis dysregulation.

Identifiants

pubmed: 33419306
pii: ijms21249733
doi: 10.3390/ijms21249733
pmc: PMC7766406
pii:
doi:

Substances chimiques

IGF1 protein, human 0
Insulin-Like Growth Factor I 67763-96-6
Nickel 7OV03QG267
Growth Hormone 9002-72-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Prev Med. 2020 Jan 03;11:2
pubmed: 32042399
J Nutr Health Aging. 2016;20(9):958-963
pubmed: 27791227
Endocrine. 2015 Jun;49(2):503-11
pubmed: 25614038
Endocr Pract. 2009 Sep-Oct;15 Suppl 2:1-29
pubmed: 20228036
Endocrinology. 2011 Nov;152(11):4190-8
pubmed: 21862619
PLoS One. 2012;7(10):e47059
pubmed: 23056581
J Clin Endocrinol Metab. 1990 Aug;71(2):505-8
pubmed: 2380345
Eur J Endocrinol. 2017 Dec;177(6):R275-R285
pubmed: 28780516
Exp Cell Res. 2013 Nov 15;319(19):3020-34
pubmed: 23973924
Oxid Med Cell Longev. 2013;2013:640673
pubmed: 23577225
J Manag Care Pharm. 2003 Jan-Feb;9(1 Suppl):2-5
pubmed: 14613351
Eur J Radiol. 2007 Apr;62(1):138-42
pubmed: 17161570
J Clin Endocrinol Metab. 2020 Sep 1;105(9):
pubmed: 32484877
Nature. 2006 Dec 14;444(7121):860-7
pubmed: 17167474
Endocr Res. 2016 May;41(2):81-8
pubmed: 26726735
Nitric Oxide. 2000 Apr;4(2):129-38
pubmed: 10835293
Nutrients. 2020 Sep 20;12(9):
pubmed: 32962190
Contact Dermatitis. 2019 Oct;81(4):227-241
pubmed: 31140194
Sci Total Environ. 2020 Jun 1;719:137458
pubmed: 32112946
Int J Clin Pract. 2010 May;64(6):817-20
pubmed: 20518955
Nutrients. 2020 Jul 18;12(7):
pubmed: 32708435
Int J Obes Relat Metab Disord. 2004 Dec;28(12):1600-6
pubmed: 15543161
Nutrients. 2020 Jan 27;12(2):
pubmed: 32012661
Bull Exp Biol Med. 2016 Dec;162(2):199-202
pubmed: 27909964
PLoS One. 2015 Mar 30;10(3):e0123265
pubmed: 25822975
Dermatol Clin. 2009 Jul;27(3):355-64, vii
pubmed: 19580929
J Clin Endocrinol Metab. 2011 Jun;96(6):1587-609
pubmed: 21602453
Jpn J Radiol. 2016 Apr;34(4):258-66
pubmed: 26932404
Environ Res. 2011 Feb;111(2):266-73
pubmed: 21168833
Allergy Rhinol (Providence). 2015 Jan;6(1):56-63
pubmed: 25747857
Endocrine. 2016 Nov;54(2):342-347
pubmed: 26815904
Nature. 1973 Oct 12;245(5424):330-2
pubmed: 4357307
Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):707-16
pubmed: 24067467
Scand J Public Health. 2002;30(1):20-9
pubmed: 11928829
Indian J Med Res. 2008 Oct;128(4):412-25
pubmed: 19106437
J Clin Invest. 2012 Jan;122(1):153-62
pubmed: 22201683
PLoS One. 2018 Aug 28;13(8):e0202683
pubmed: 30153310
BMC Health Serv Res. 2017 Dec 12;17(1):819
pubmed: 29233134
Part Fibre Toxicol. 2012 Nov 05;9:40
pubmed: 23126276
Int J Obes (Lond). 2019 Jan;43(1):139-148
pubmed: 29717276
Int J Mol Sci. 2016 Feb 02;17(2):
pubmed: 26848658
Life Sci. 1984 Oct 22;35(17):1747-54
pubmed: 6090848
Endocr Rev. 2017 Aug 1;38(4):267-296
pubmed: 28898979
Islets. 2009 Nov-Dec;1(3):169-76
pubmed: 21099269
Curr Cardiol Rep. 2020 Mar 12;22(4):25
pubmed: 32166448
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Nutrients. 2018 May 09;10(5):
pubmed: 29747432
Contact Dermatitis. 2017 Oct;77(4):193-200
pubmed: 28730624
Pediatrics. 2020 May;145(5):
pubmed: 32341178
Pediatr Radiol. 2018 May;48(5):694-700
pubmed: 29508041
J Pediatr Endocrinol Metab. 2016 Oct 1;29(10):1195-1200
pubmed: 27710916
Eur J Endocrinol. 2007 Dec;157(6):695-700
pubmed: 18057375
Biochem J. 1974 May;140(2):135-42
pubmed: 4375956
Eat Weight Disord. 2020 May 25;:
pubmed: 32451949
Med Sci Monit. 2018 Dec 30;24:9473-9478
pubmed: 30594946
Mol Cell Endocrinol. 2010 Mar 25;316(2):147-53
pubmed: 19723558
Environ Res. 2020 Aug;187:109541
pubmed: 32445945
PLoS One. 2016 Jan 07;11(1):e0145811
pubmed: 26741958
Mediators Inflamm. 2018 Aug 14;2018:5427089
pubmed: 30186037
Obes Rev. 2020 Aug;21(8):e13024
pubmed: 32207237
BMJ Open. 2017 Jan 23;7(1):e014215
pubmed: 28115335
J Biol Chem. 1983 Jul 25;258(14):8618-22
pubmed: 6408091
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):131-6
pubmed: 24674689
J Endocrinol Invest. 2019 Nov;42(11):1365-1386
pubmed: 31111407
Am J Med. 2015 Mar;128(3):229-38
pubmed: 25447615
Am J Clin Nutr. 1997 Sep;66(3):616-21
pubmed: 9280182
Endocrine. 2015 Apr;48(3):863-70
pubmed: 25063307
Toxicol Appl Pharmacol. 2013 Dec 15;273(3):492-9
pubmed: 24080332
Acta Radiol. 1998 Jan;39(1):64-9
pubmed: 9498873

Auteurs

Renata Risi (R)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Simonetta Masieri (S)

Department of Sensory Organs, Sapienza University of Rome, 00161 Rome, Italy.

Eleonora Poggiogalle (E)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Mikiko Watanabe (M)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Alessandra Caputi (A)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Rossella Tozzi (R)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Elena Gangitano (E)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Davide Masi (D)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Stefania Mariani (S)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Lucio Gnessi (L)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Carla Lubrano (C)

Department of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Viale Regina Elena, 324, 00161 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH